Full Free Text at:
J Biol Chem 2003 Jan 27
Luttichau HR, Lewis IC, Jensen PO, Moser C, Gerstoft J, Schwartz TW.
Department for Pharmacology, Panum Institute, Copenhagen N 2200.
The chemokine-like, secreted protein product of the U83 gene from human herpes virus 6 here named vCCL4 - was chemically synthesized to be characterized in a complete library of the eighteen known human chemokine receptors expressed individually in stably transfected cell lines.
vCCL4 was found to cause calcium mobilization as efficiently as the endogenous chemokine ligand CCL2 through the CCR2 receptor whereas the virally encoded chemokine did not affect any of the other seventeen human chemokine receptors tested.
Mutual cross desensitization between CCL2 and vCCL4 was demonstrated in the CCR2 transfected cells.
The affinity of vCCL4 for the CCR2 receptor was 79 nM as determined in competition binding against radioactively labeled CCL2.
In the murine pre-B lymphocyte cell line L1.2 stably transfected with the CCR2 receptor, vCCL4 acted as a relatively low potency but highly efficacious chemoattractant being equally or more efficacious in causing cell migration than CCL2 and CCL7 and considerably more efficacious than CCL8 and CCL13.
It is concluded that human herpes virus 6 encodes a highly selective and efficacious CCR2 agonist, which will attract CCR2 expressing cells - for example macrophages and monocytes - conceivably for the virus to infect and establish latency in.
It is suggested that vCCL4 during reactivation of the virus in for example monocyte-derived microglia could perhaps be involved in the pathogenesis of the CCR2 dependent disease, multiple sclerosis.